
( Brand: Spectranetics ), ( Manufacturer Part Number: 545-509 )
The Spectranetics 545-509 TightRail Reperfusion Catheter is a state-of-the-art interventional device designed for the treatment of critically obstructed coronary arteries. This catheter is part of the TightRail family of products, which are known for their innovative design and exceptional performance in complex interventions.
The 545-509 model is specifically designed for use in vessels with a diameter ranging from 2.25 to 3.50 mm. It features a low-profile, tapered shape that allows for easy navigation through narrow and tortuous coronary arteries. The catheter is made of nitinol, a highly flexible and shape-memory alloy, enabling it to conform to the contours of the vessel and maintain its shape once positioned.
One of the most notable features of the 545-509 TightRail Reperfusion Catheter is its integrated, low-profile infusion system. This system allows for the infusion of various therapeutic agents, such as thrombolytics, to facilitate the reperfusion of the obstructed artery. The infusion port is designed to minimize flow disturbance, ensuring efficient delivery of the therapeutic agent to the treatment site.
The catheter also comes equipped with a dual-lumen design, which allows for simultaneous delivery of contrast media and therapeutic agents. This feature is particularly useful during diagnostic and interventional procedures, as it enables real-time visualization of the treatment site while administering therapeutic agents.
The 545-509 TightRail Reperfusion Catheter is also compatible with various guiding catheters and introducer sheaths, making it a versatile addition to any interventional lab. Its robust design and precise engineering ensure reliable performance in even the most challenging interventions.
In summary, the Spectranetics 545-509 TightRail Reperfusion Catheter is a high-performance interventional device designed for the treatment of critically obstructed coronary arteries. Its innovative features, including a low-profile, tapered shape, integrated infusion system, and dual-lumen design, make it an indispensable tool for interventional cardiologists and radiologists.
The Spectranetics 545-509 TightRail Endovascular System is a medical device used in the treatment of peripheral arterial disease (PAD). PAD is a condition characterized by the narrowing or blockage of the peripheral arteries, which can lead to pain, cramping, and decreased blood flow to the limbs. The TightRail System is designed to deliver a laser-assisted thrombectomy and recanalization of the affected artery. Here are some pros and cons of using this system:
Pros:1. Minimally Invasive: The TightRail System is a minimally invasive treatment option for PAD. It does not require major surgery and allows for quicker recovery times as compared to traditional surgical methods.
2. Effective Thrombectomy: The laser-assisted thrombectomy function of the TightRail System is highly effective in removing blood clots from the affected artery. This can significantly improve blood flow and reduce pain and cramping in the affected limb.
3. Flexible Design: The TightRail System is designed to conform to the shape of the artery, allowing for precise delivery to the treatment site. This flexibility also enables the device to navigate complex vascular anatomy.
4. Reduced Risk of Complications: Compared to surgical options, the TightRail System carries a lower risk of complications such as infection, bleeding, and damage to healthy tissue.
Cons:1. Cost: The TightRail System is an expensive medical device. The cost of the device, as well as the associated procedural costs, can be a significant barrier to its widespread use.
2. Training and Experience: The use of the TightRail System requires specialized training and experience. Healthcare providers must undergo extensive training to become proficient in using the device, which can add to the overall cost and complexity of the procedure.
3. Limited Indications: The TightRail System is not suitable for all cases of PAD. It is most effective in treating smaller vessels with minimal calcification. In more complex cases, traditional surgical methods may be more appropriate.
Conclusion:The Spectranetics 545-509 TightRail Endovascular System is a highly effective, minimally invasive treatment option for peripheral arterial disease. Its ability to deliver precise thrombectomy and recanalization, as well as its flexible design, make it an attractive choice for many healthcare providers. However, its high cost and the need for specialized training and experience limit its widespread use. Ultimately, the decision to use the TightRail System should be made on a case-by-case basis, taking into consideration the individual patient's needs and the availability of alternative treatment options.
Recommendation:The TightRail System is an excellent option for healthcare providers treating patients with peripheral arterial disease who require a minimally invasive approach. Its effectiveness in removing blood clots and improving blood flow make it a valuable tool in the treatment of PAD. However, due to its high cost and the need for specialized training and experience, it may not be the best choice for all patients or healthcare facilities. Healthcare providers should carefully consider the individual patient's needs and the availability of alternative treatment options before deciding to use the TightRail System.
Dickson Corporation. If it is not pictured or stated as included, then included. SPECTRANETICS TIGHTRAIL 545-509.: This is new, exp 5/25.